Market opens at record high; Sensex rallies over 350 points

After touching its lifetime peak of 42,959.25 in the opening session, the 30-share BSE index was trading 216.15 points or 0.51% higher at 42,813.58.

November 10, 2020 12:41 pm | Updated 12:41 pm IST - Mumbai

Mumbai: Pedestrians walk past the Bombay Stock Exchange (BSE) building, in Mumbai, Friday, June 12, 2020. Equity benchmark Sensex rebounded from a sharp selloff in early trade to finish 243 points higher on Friday, led by strong gains in Reliance Industries and a rebound in European markets. (PTI Photo)
(PTI12-06-2020_000100B)

Mumbai: Pedestrians walk past the Bombay Stock Exchange (BSE) building, in Mumbai, Friday, June 12, 2020. Equity benchmark Sensex rebounded from a sharp selloff in early trade to finish 243 points higher on Friday, led by strong gains in Reliance Industries and a rebound in European markets. (PTI Photo)
 (PTI12-06-2020_000100B)

Equity benchmark Sensex opened over 350 points higher to hit its record intra-day level on November 10, tracking a global market rally driven by Pfizer’s progress in the development of COVID-19 vaccine amid persistent foreign fund inflow.

After touching its lifetime peak of 42,959.25 in the opening session, the 30-share BSE index was trading 216.15 points or 0.51% higher at 42,813.58.

Similarly, the broader NSE Nifty too claimed a fresh high of 12,557.05. Later, it was trading with 51.65 points or 0.41% gain at 12,512.70.

ICICI Bank was the top gainer, surging around 3%, followed by ONGC, HDFC, L&T, SBI, HDFC Bank, IndusInd Bank and Bajaj Finance.

On the other hand, Tech Mahindra, Infosys, HCL Tech, TCS, Nestle India and Maruti were in the red.

In the previous session, Sensex ended 704.37 points or 1.68% higher at 42,597.43 — its record closing high. The Nifty too closed at a lifetime high of 12,461.05, up 197.50 points or 1.61%.

Trade set up in domestic equities continues to look good with Asian markets trading in green with handsome gains, said Arjun Yash Mahajan Head Institutional Business at Reliance Securities.

“Clarity over COVID-19 vaccine is likely to ease the concerns of the possible second wave of coronavirus in India, which essentially means that revival of economic activities should persist. The domestic market should continue to see traction in the equities market in the near term,” he said.

Amid positive signals, investors were also cautious ahead of the Bihar Assembly election results, traders said.

Pfizer and BioNTech on November 9 said their vaccine candidate was found to be more than 90% effective in preventing COVID-19.

U.S. equities ended mostly higher as positive news about the COVID-19 vaccine bolstered investor confidence further.

Elsewhere in Asia, bourses in Shanghai, Hong Kong and Tokyo were trading up to 0.74% higher in mid-session deals, while Seoul was flat.

Foreign institutional investors remained net buyers in the capital market as they purchased shares worth ₹4,548.39 crore on November 9, according to provisional exchange data.

Meanwhile, international oil benchmark Brent crude was trading 1.23% lower at $41.88 per barrel.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.